Companies
Are Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) Prospects Worsening?
Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) Relative Strength Index (RSI) is 45.25, with weekly volatility at 12.96% and ATR at 0.18. The CATB stock’s 52-week price range